322 related articles for article (PubMed ID: 17992259)
1. The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity.
Hanai J; Cao P; Tanksale P; Imamura S; Koshimizu E; Zhao J; Kishi S; Yamashita M; Phillips PS; Sukhatme VP; Lecker SH
J Clin Invest; 2007 Dec; 117(12):3940-51. PubMed ID: 17992259
[TBL] [Abstract][Full Text] [Related]
2. Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect.
Cao P; Hanai J; Tanksale P; Imamura S; Sukhatme VP; Lecker SH
FASEB J; 2009 Sep; 23(9):2844-54. PubMed ID: 19406843
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.
Gonçalves DA; Lira EC; Baviera AM; Cao P; Zanon NM; Arany Z; Bedard N; Tanksale P; Wing SS; Lecker SH; Kettelhut IC; Navegantes LC
Endocrinology; 2009 Dec; 150(12):5395-404. PubMed ID: 19837877
[TBL] [Abstract][Full Text] [Related]
4. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
5. Atrogin-1 promotes muscle homeostasis by regulating levels of endoplasmic reticulum chaperone BiP.
Ruparelia AA; Montandon M; Merriner J; Huang C; Wong SFL; Sonntag C; Hardee JP; Lynch GS; Miles LB; Siegel A; Hall TE; Schittenhelm RB; Currie PD
JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38530354
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for statin-induced muscle toxicity: implications and possibilities.
Buettner C; Lecker SH
Pharmacogenomics; 2008 Aug; 9(8):1133-42. PubMed ID: 18681786
[TBL] [Abstract][Full Text] [Related]
7. Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo.
Goodman CA; McNally RM; Hoffmann FM; Hornberger TA
Mol Endocrinol; 2013 Nov; 27(11):1946-57. PubMed ID: 24002653
[TBL] [Abstract][Full Text] [Related]
8. Effect of dexamethasone on the expression of atrogin-1/MAFbx in chick skeletal muscle.
Nakashima K; Ishida A; Ijiri D; Ohtsuka A
Anim Sci J; 2016 Mar; 87(3):405-10. PubMed ID: 26279163
[TBL] [Abstract][Full Text] [Related]
9. A novel hindlimb immobilization procedure for studying skeletal muscle atrophy and recovery in mouse.
Caron AZ; Drouin G; Desrosiers J; Trensz F; Grenier G
J Appl Physiol (1985); 2009 Jun; 106(6):2049-59. PubMed ID: 19342435
[TBL] [Abstract][Full Text] [Related]
10. Sepsis and glucocorticoids downregulate the expression of the nuclear cofactor PGC-1beta in skeletal muscle.
Menconi MJ; Arany ZP; Alamdari N; Aversa Z; Gonnella P; O'Neal P; Smith IJ; Tizio S; Hasselgren PO
Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E533-43. PubMed ID: 20647557
[TBL] [Abstract][Full Text] [Related]
11. Atrogin-1 affects muscle protein synthesis and degradation when energy metabolism is impaired by the antidiabetes drug berberine.
Wang H; Liu D; Cao P; Lecker S; Hu Z
Diabetes; 2010 Aug; 59(8):1879-89. PubMed ID: 20522589
[TBL] [Abstract][Full Text] [Related]
12. Aging affects the transcriptional regulation of human skeletal muscle disuse atrophy.
Suetta C; Frandsen U; Jensen L; Jensen MM; Jespersen JG; Hvid LG; Bayer M; Petersson SJ; Schrøder HD; Andersen JL; Heinemeier KM; Aagaard P; Schjerling P; Kjaer M
PLoS One; 2012; 7(12):e51238. PubMed ID: 23284670
[TBL] [Abstract][Full Text] [Related]
13. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.
Sandri M; Sandri C; Gilbert A; Skurk C; Calabria E; Picard A; Walsh K; Schiaffino S; Lecker SH; Goldberg AL
Cell; 2004 Apr; 117(3):399-412. PubMed ID: 15109499
[TBL] [Abstract][Full Text] [Related]
14. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
15. Opposite roles of myocardin and atrogin-1 in L6 myoblast differentiation.
Jiang Y; Singh P; Yin H; Zhou YX; Gui Y; Wang DZ; Zheng XL; ;
J Cell Physiol; 2013 Oct; 228(10):1989-95. PubMed ID: 23526547
[TBL] [Abstract][Full Text] [Related]
16. β
Shimamoto S; Ijiri D; Kawaguchi M; Nakashima K; Tada O; Inoue H; Ohtsuka A
Comp Biochem Physiol A Mol Integr Physiol; 2017 Sep; 211():1-6. PubMed ID: 28578076
[TBL] [Abstract][Full Text] [Related]
17. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome.
Kang SH; Lee HA; Kim M; Lee E; Sohn UD; Kim I
Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E495-E507. PubMed ID: 28246104
[TBL] [Abstract][Full Text] [Related]
18. Flavones Inhibit LPS-Induced Atrogin-1/MAFbx Expression in Mouse C2C12 Skeletal Myotubes.
Shiota C; Abe T; Kawai N; Ohno A; Teshima-Kondo S; Mori H; Terao J; Tanaka E; Nikawa T
J Nutr Sci Vitaminol (Tokyo); 2015; 61(2):188-94. PubMed ID: 26052151
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo.
Lagirand-Cantaloube J; Cornille K; Csibi A; Batonnet-Pichon S; Leibovitch MP; Leibovitch SA
PLoS One; 2009; 4(3):e4973. PubMed ID: 19319192
[TBL] [Abstract][Full Text] [Related]
20. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
